DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Xanthopoulos A, Tryposkiadis K, Triposkiadis F. et al.
Postimplant phosphodiesterase type 5 inhibitors use is associated with lower rates of thrombotic events after left ventricular assist device implantation.
J Am Heart Assoc 2020;
9 (14) e015897
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.